Long-Term Safety and Efficacy of Spark-Sponsored Gene Therapies in Males With Hemophilia A
Clinical trial NCT03432520 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03432520
- Sponsor
- Spark Therapeutics, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2018-08-14
- Primary completion
- 2032-12-01
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.